4
MARKET OVERVIEW
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN ASIA PACIFIC HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE SELLING PRICE OF ASIA PACIFIC HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT (2024)
5.5.2
INDICATIVE SELLING PRICE OF ASIA PACIFIC HEALTHCARE ANALYTICS SOLUTIONS, BY COUNTRY (2024)
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
5.10
IMPACT OF 2025 US TARIFF – ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN THE ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ASIA PACIFIC HEALTHCARE ANALYTICS MARKET
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY COMPONENT (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
9.2.1.1
ANALYTICAL SERVICES
9.2.1.2
CONSULTING SERVICES
9.2.2
PROFESSIONAL SERVICES
9.2.2.1
TRAINING & IMPLEMENTATION SERVICES
9.2.2.2
MAINTENANCE & SUPPORT SERVICES
9.3.1
ON-PREMISE SOFTWARE
9.3.2
CLOUD-BASED SOFTWARE
10
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY TYPE (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
10.2
DESCRIPTIVE ANALYTICS
10.3
PREDICTIVE ANALYTICS
10.4
PRESCRIPTIVE ANALYTICS
10.5
DIAGNOSTIC ANALYTICS
11
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY APPLICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
11.2.2
REVENUE CYCLE MANAGEMENT
11.2.3
PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
11.2.4
RISK ADJUSTMENT & ASSESSMENT
11.3.1
QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
11.3.2
CLINICAL DECISION SUPPORT
11.2.3
REPORTING & COMPLIANCE
11.2.4
COMPARATIVE ANALYTICS/EFFECTIVENESS
11.2.5
PRECISION HEALTH/REAL-WORLD EVIDENCE
11.2.6
MEDICAL IMAGING ANALYTICS
11.4
OPERATIONAL & ADMINISTRATIVE ANALYTICS
11.4.1
SUPPLY CHAIN ANALYTICS
11.4.2
WORKFORCE ANALYTICS
11.4.3
REPORTING & COMPLIANCE
11.5
POPULATION HEALTH ANALYTICS
12
ASIA PACIFIC HEALTHCARE ANALYTICS MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
12.2.1
PRIVATE INSURANCE COMPANIES
12.2.2
GOVERNMENT AGENCIES
12.3.1
HOSPITALS & CLINICS
12.3.2
POST-ACUTE CARE ORGANIZATIONS
12.3.3
AMBULATORY SURGERY CENTERS
12.4
PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
12.4.2
DISTRIBUTORS & WHOLESALERS
13
ASIA PACIFIC TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
13.4.6
REST OF ASIA PACIFIC
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
14.3
REVENUE ANALYSIS (2020–2024)
14.4
MARKET SHARE ANALYSIS (2024)
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.6.5.1
COMPANY FOOTPRINT
14.6.5.2
COUNTRY FOOTPRINT
14.6.5.3
COMPONENT FOOTPRINT
14.6.5.4
APPLICATION FOOTPRINT
14.6.5.5
END-USER FOOTPRINT
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
14.7.1
PROGRESSIVE COMPANIES
14.7.2
RESPONSIVE COMPANIES
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
14.8
COMPANY VALUATION AND FINANCIAL METRICS
14.9
COMPETITIVE SCENARIO
14.9.4
OTHER DEVELOPMENTS
15.1.2
SAS INSTITUTE INC.
15.1.6
EXLSERVICE HOLDINGS, INC.
15.1.11
MCKESSON CORPORATION
15.1.15
KOMODO HEALTH, INC.
15.1.18
INTERSYSTEMS CORPORATION
15.1.19
KONINKLIJKE PHILIPS N.V.
15.2.2
HEAPS HEALTH SOLUTIONS INDIA PRIVATE LIMITED
15.2.3
MYHEALTHCARE TECHNOLOGIES PRIVATE LIMITED
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
BASE NUMBER CALCULATION
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Asia Pacific Healthcare Analytics Market